Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Bristol Myers Squibb - Therapeutic Advances in GI Cancers: Immuno-Oncology and Beyond

Hepatocellular Carcinoma: First-line Treatment Options in the Metastatic Setting

Date

13 Sep 2024

Session

Bristol Myers Squibb - Therapeutic Advances in GI Cancers: Immuno-Oncology and Beyond

Topics

Tumour Site

Gastric Cancer

Presenters

Thomas Decaens

Authors

T. Decaens

Author affiliations

  • Hepato-gastroenterology, CHU Grenoble-Alpes - Le site nord à La Tronche - Hopital Michallon, 38700 - La Tronche/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and Introduction

Presenter: Sara Lonardi

Session: Bristol Myers Squibb - Therapeutic Advances in GI Cancers: Immuno-Oncology and Beyond

Resources:

Webcast

Summary and Close

Presenter: Sara Lonardi

Session: Bristol Myers Squibb - Therapeutic Advances in GI Cancers: Immuno-Oncology and Beyond

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.